Connective Capital Management LLC Acquires Shares of 178,615 Applied DNA Sciences, Inc. (NASDAQ:APDN)

Connective Capital Management LLC purchased a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 178,615 shares of the technology company’s stock, valued at approximately $36,000. Connective Capital Management LLC owned approximately 0.32% of Applied DNA Sciences as of its most recent SEC filing.

Separately, Geode Capital Management LLC boosted its position in shares of Applied DNA Sciences by 291.1% during the fourth quarter. Geode Capital Management LLC now owns 417,485 shares of the technology company’s stock worth $85,000 after purchasing an additional 310,749 shares in the last quarter. 22.22% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on shares of Applied DNA Sciences in a research report on Monday, March 17th. They set a “sell” rating on the stock.

Applied DNA Sciences Stock Down 7.5%

Shares of NASDAQ APDN opened at $0.60 on Wednesday. The company’s fifty day moving average is $1.20 and its 200-day moving average is $6.13. The stock has a market cap of $659,088.00, a price-to-earnings ratio of -0.10 and a beta of 0.41. Applied DNA Sciences, Inc. has a twelve month low of $0.57 and a twelve month high of $177.00.

Applied DNA Sciences (NASDAQ:APDN) last announced its quarterly earnings results on Thursday, May 15th. The technology company reported ($15.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.00) by ($12.35). The firm had revenue of $0.98 million for the quarter, compared to the consensus estimate of $1.19 million. Applied DNA Sciences had a negative return on equity of 101.57% and a negative net margin of 228.12%. On average, research analysts anticipate that Applied DNA Sciences, Inc. will post -0.87 EPS for the current fiscal year.

Applied DNA Sciences Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.